Literature review highlights the role of antiviral medications and laser therapy in managing oral herpetic lesions.
Oral herpetic lesions, primarily caused by the herpes simplex virus (HSV), present a significant therapeutic challenge due to their recurrent nature and impact on patient quality of life. After latency onset, HSV-1 can reactivate, causing frequent recurrences in some patients, while most individuals have few recurrences. Traditional treatment options for managing oral herpes include antiviral medications. These antiviral therapies function by inhibiting viral replication and alleviating symptoms, thus reducing the duration of lesions. These treatments have consistently demonstrated efficacy in reducing the duration and severity of lesions; however, their effectiveness can vary depending on the timing of administration, with early intervention yielding more favorable results.
No takes yet. Share an insight, caveat, or question.
Ribeiro et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: